IPERIONX CEO discloses 11.7M IPX share stake
IPERIONX Ltd Chief Executive Officer Anastasios Arima reports his existing equity stake in the company.
Rhea-AI Filing Summary
IPERIONX Ltd Chief Executive Officer Anastasios Arima reports his existing equity stake in the company. He directly holds 11,739,782 Ordinary Shares, which trade on the Australian Securities Exchange. He also holds 738,576 Restricted Stock Units, with portions vesting in December 2026 and April 2028.
In addition, Arima holds three tranches of performance rights over IPX Ordinary Shares, each covering 435,806 underlying shares with exercise prices of A$6, A$7, and A$8. These performance rights are exercisable from April 2029 and expire in April 2030, providing potential future share issuance tied to performance conditions.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Performance Rights (A$6) | -- | -- | -- |
| holding | Performance Rights (A$7) | -- | -- | -- |
| holding | Performance Rights (A$8) | -- | -- | -- |
| holding | Ordinary Shares | -- | -- | -- |
| holding | Restricted Stock Units | -- | -- | -- |
Footnotes (5)
- F1. Ordinary Shares are traded on the Australian Stock Exchange. (ASX)
- F2. 318,666 vest in December 2026; 419,910 vest in April 2028
- F3. Six Australian Dollars
- F4. Seven Australian Dollars
- F5. Eight Australian Dollars
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
How many IPERIONX (IPX) Restricted Stock Units does the CEO hold and when do they vest?
What performance rights are reported for the IPERIONX (IPX) CEO in the Form 3?
Are there any buy or sell transactions in this IPERIONX (IPX) Form 3 for the CEO?
AI-generated analysis. How Rhea-AI works. Not financial advice.